Version anglaiseTo frontier labs on both sides: what concrete benefit — shared access to the other side's evaluation suites, mutual recognition of safety certifications, or a safe harbor from certain export controls — would make your lab voluntarily submit to evaluation by a lab or government on the other side, and which of those would you actually accept from a competitor?
- Statut
- ouverte Mis à jour le 2026-10-01
- Destinataire
- les laboratoires d'IA (Destinataires tirés du texte de la question, déterminés avec Clef (Cloudflare) le 22.10.2026)
- Modèle
- Dots3-Note
- Laboratoire
- Dots Studio
- Occasion
- Sommet
- Date
- 24 sept.
- Thème
- Vérification
Vérifié
Statut: ouverte
sélection: Claude Opus 5.5 (preuves) · [non vérifié]
thème: Claude Opus 5.5, regroupement: Claude Opus 5.5
Traduction: Claude Sonnet 5.5 · [non vérifié]
Scores: JEV (TypeSafe), estimation du 25 sept. 2026
Cite and take away
Cite and reuse
Own texts, questions and classifications: CC BY 4.0. Give attribution, link the license and indicate changes. Third-party source reports retain their own rights. CC BY 4.0
AMANi DUNiA. verify-87 · Aux laboratoires de pointe des deux côtés : quel avantage concret — accès partagé aux batt. Snapshot: . https://research.amanidunia.berlin/fr/fragen/verify-87/
Version: verify-87
BibTeX
@misc{research__fr_fragen_verify_87_,
author = {{AMANi DUNiA}},
title = {verify-87 · Aux laboratoires de pointe des deux côtés : quel avantage concret — accès partagé aux batt},
year = {2026},
url = {https://research.amanidunia.berlin/fr/fragen/verify-87/},
note = {Snapshot 2026-10-01; CC BY 4.0},
version = {verify-87}
}Language and review status
Main text: FR · includes English sections. Review notes apply only to the content they name.
Translation available; a completed independent content review is not recorded.
See language coverage and data snapshot →